14 research outputs found

    Isomeric Replacement of a Single Aspartic Acid Induces a Marked Change in Protein Function: The Example of Ribonuclease A

    No full text
    lĪ±-Aspartic acid (Asp) residues in proteins are nonenzymatically isomerized to abnormal lĪ²-, dĪ±-, and dĪ²-Asp isomers under physiological conditions. Such an isomerization of Asp residues is considered to be a trigger of protein denaturation because it either elongates the main chain or induces a different orientation of the side chain within the protein structure or both. However, previous studies have found no direct evidence of the effects of Asp isomers on protein function. Therefore, the production of Asp-isomer-containing proteins is required to verify the effects of Asp isomerization. Here, we describe the production of an Asp-isomer-containing protein using the expressed protein ligation. As a model protein, bovine pancreatic ribonuclease A (RNase A, EC 3.1.27.5), which catalyzes the cleavage of phosphodiester bonds in RNA, was used. In this study, lĪ±-Asp at position 121 in RNase A was replaced by lĪ²-, dĪ±-, and dĪ²-Asp. The objective aspartic acid at position 121 is located near the active site and related to RNA cleavage. The RNase A with lĪ±-Asp at position 121 showed a normal activity. By contrast, the catalytic activity of lĪ²-, dĪ±-, and dĪ²-Asp-containing RNase A was markedly decreased. This study represents the first synthesis and analysis of a protein containing four different Asp isomers

    Profile of miRNAs in small extracellular vesicles released from glioblastoma cells treated by boron neutron capture therapy

    No full text
    Purpose: Boron neutron capture therapy (BNCT) is a tumor cell-selective particle-radiation therapy. In BNCT, administered p-boronophenylalanine (BPA) is selectively taken up by tumor cells, and the tumor is irradiated with thermal neutrons. High-LET Ī±-particles and recoil ā·Li, which have a path length of 5ā€“9 Ī¼m, are generated by the capture reaction between Ā¹ā°B and thermal neutrons and selectively kill tumor cells that have uptaken Ā¹ā°B. Although BNCT has prolonged the survival time of malignant glioma patients, recurrences are still to be resolved. miRNAs, that are encapsulated in small extracellular vesicles (sEVs) in body fluids and exist stably may serve critical role in recurrence. In this study, we comprehensively investigated microRNAs (miRNAs) in sEVs released from post-BNCT glioblastoma cells. Method: Glioblastoma U87 MG cells were treated with 25 ppm of BPA in the culture media and irradiated with thermal neutrons. After irradiation, they were plated into dishes and cultured for 3 days in the 5% COā‚‚ incubator. Then, sEVs released into the medium were collected by column chromatography, and miRNAs in sEVs were comprehensively investigated using microarrays. Result: An increase in 20 individual miRNAs (ratioā€‰>ā€‰2) and a decrease in 2 individual miRNAs (ratioā€‰<ā€‰0.5) were detected in BNCT cells compared with non-irradiated cells. Among detected miRNAs, 20 miRNAs were associated with worse prognosis of glioma in Kaplan Meier Survival Analysis of overall survival in TCGA. Conclusion: These miRNA after BNCT may proceed tumors, modulate radiation resistance, or inhibit invasion and affect the prognosis of glioma

    Identification of į“…-amino acid-containing peptides in human serum

    No full text
    <div><p>Biologically uncommon d-aspartate (d-Asp) residues have been shown to accumulate in proteins associated with age-related human disorders, such as cataract and Alzheimer disease. Such d-Asp-containing proteins are unlikely to be broken down completely because metabolic enzymes recognize only proteins or peptides composed exclusively of l-amino acids. Therefore, undigested d-Asp-containing peptides may exist in blood and, if detectable, may be a useful biomarker for associated diseases. In this study, we investigated d-amino acid-containing peptides in adult human serum by a qualitative d-amino acid analysis based on a diastereomer method and LC-MS/MS method. As a result, two d-Asp-containing peptides were detected in serum, both derived from the fibrinogen Ī²-chain, a glycoprotein that helps in the formation of blood clots. One of the peptides was fibrinopeptide B, which prevents fibrinogen from forming polymers of fibrin, and the other was same peptide with C-terminal Arginine missing. To our knowledge, this is the first report of the presence of d-amino acid-containing peptides in serum and the approach described will provide a new direction on the serum proteome and fragmentome.</p></div

    Isolation of peptides from human serum.

    No full text
    <p>RP-HPLC chromatogram of the serum peptides from the donor aged ~60 years. The detailed RP-HPLC conditions are described in Materials and Methods. Arrows indicate d-Asp-containing peptides.</p

    Determination of the d/l ratio of Asp in human serum-derived peptides.

    No full text
    <p>Elution profile of the enantiomeric separation of Asp derivatives using Boc-l-Cys-OPA. Aspartate residues from the hydrolysates of peptide peaks 16 (<b>a</b>) and 18 (<b>b</b>) in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0189972#pone.0189972.g001" target="_blank">Fig 1</a> (serum sample from the donor aged ~60 years) are shown. The d/l ratio of Asp was estimated as 0.08 in both peaks by calculating the peak areas of the chromatograms.</p

    Identification of d-Asp-containing peptides by LC-MS/MS analysis.

    No full text
    <p>(<b>a</b>) LC-MS chromatogram of peak 16 in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0189972#pone.0189972.g001" target="_blank">Fig 1</a>. This peptide was separated into two peaks with the same mass ([M+2H]<sup>2+</sup> = 777.5), indicating two isomers of the same peptide. (<b>b-1</b>) Tandem mass spectrum of the large peak in (<b>a</b>). (<b>b-2</b>) Tandem mass spectrum of the small peak in (<b>a</b>). (<b>c</b>) LC-MS chromatogram of peak 18 ([M+2H]<sup>2+</sup> = 698.9) in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0189972#pone.0189972.g001" target="_blank">Fig 1</a>. (<b>d</b>) Tandem mass spectrum of the peak in (<b>c</b>). Both peptides were identified as fibrinogen Ī²-chain-specific peptides (peak 16, <sup>1</sup>QGVNDNEEGFFSAR<sup>14</sup>; and peak 18, <sup>1</sup>QGVNDNEEGFFSA<sup>13</sup>). The N-terminal Gln residue was converted to pyro-Glu in both peptides.</p

    Localization of D-Ī²-Aspartyl Residue-Containing Proteins in Various Tissues

    No full text
    Prior to the emergence of life, it is believed that only L-amino acids were selected for formation of protein and that D-amino acids were eliminated on the primitive Earth. Whilst homochirality is essential for life, the occurrence of proteins containing D-Ī²-aspartyl (Asp) residues in various tissues from elderly subjects has been reported recently. Here, we demonstrate the presence of a D-Ī²-Asp-containing protein in the cardiac muscle of heart, blood vessels of the lung, chief cells of the stomach, longitudinal and circular muscle of the stomach, small intestine and large intestine. Since the D-Ī²-Asp residue occurs through a succinimide intermediate, this isomer may potentially be generated in proteins more easily than initially thought. Formation of the D-Ī²-Asp residue in proteins may be related to stress
    corecore